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Abstract Poly-ADP ribosylation of nuclear proteins is acti- 
vated when poly(ADP-ribose) polymerase (PARP), a nuclear 
zinc-finger enzyme, binds to single-strand DNA breaks. To 
understand how the signal emerging from its DNA-binding 
domain (DBD) bound to such breaks is transduced to its catalytic 
domain, the structure-function relationship of the DBD was 
investigated. We have used mutagenesis by the polymerase chain 
reaction (PCR) to generate a random library of PARP mutants. 
In this work, we describe the identification of catalytically 
inactive mutants bearing single point mutations, located outside 
the two zinc fingers in the DBD, that have conserved their full 
capacity to bind DNA. The results obtained demonstrate that the 
DNA-dependent activation of PARP requires not only a capacity 
to bind DNA but also a number of crucial residues to maintain a 
conformation of the domain necessary to transfer an 'activation 
signal' to the catalytic domain. 
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1. Introduction 
In living cells, DNA is continuously subjected to genotoxic 
damage that can lead to DNA strand-breaks, either directly or 
ndirectly following specific recognition and excision of the 
iesion. To protect he genome from the deleterious accumula- 
ion of damage, cells have developed an intricate DNA sur- 
veillance network. Poly(ADP-ribose) polymerase (PARP, EC 
?..4.2.30) is a nuclear protein involved in this process as a 
~nolecular nick-sensor [1]. At the site of a DNA strand-break, 
I'ARP catalyses the transfer of the ADP-ribose moiety from 
aicotinamide adenine dinucleotide (NAD+), to a limited num- 
I~er of nuclear proteins involved in chromatin architecture, 
DNA metabolism, and to PARP itself [for a review see [2], 
13]]. Although the precise biological role of the enzyme has 
hot been fully elucidated, PARP has emerged in the last dec- 
ade as a critical regulatory component in the base excision 
"epair (BER) pathway [4-7]. 
PARP has a modular organization [1] as shown in Fig. IA. 
It is a multifunctional, highly conserved enzyme which detects 
md binds tightly to DNA single-strand breaks via its N-ter- 
ninal DNA-binding domain (DBD) which subsequentley sta- 
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bilizes a V-shaped, nicked-DNA conformation [8]. This region 
encompasses two zinc fingers (domain A), presumably result- 
ing from the duplication of an ancestral motif (exons 1-2 
encoding the amino acid sequence 1-97 and exons 3~1 encod- 
ing the sequence 98-196) which is involved in the detection of 
DNA breaks [9-11]. Domain B corresponds to a bipartite, 
nuclear localization signal [12]. At a site of DNA strand- 
break, the basal activity of the C-terminal catalytic domain 
(domain F) is stimulated over 500 times in a DNA-dependent 
manner [13]. Recently, the crystallographic structure of the 
chicken PARP catalytic domain has been solved revealing 
surprising structural homology between its active site (Fig. 
1A, residues 859-908) and bacterial mono-ADP ribosylating 
toxins in spite of a weak sequence homology [14]. 
To examine the structure function relationship of the 
PARP DBD, we and others have previously identified poten- 
tial critical residues that impair the stimulation of poly-ADP 
ribosylation by DNA strand-breaks. These residues not sur- 
prisingly were the cysteine and histidine ligands of the two 
zinc ions [10,11] and arginine-138 which is located in a puta- 
tive c~-helix of the second zinc finger [4]. 
To date, the mechanism of stimulation of the catalytic do- 
main following recognition and binding of the DBD to DNA 
strand-breaks is not understood. In the present study, we have 
developed an in vitro PCR random mutagenesis a say to gen- 
erate a library of PARP DBD mutants that were expressed in 
Escherichia coli. This library of mutants was subsequently 
screened for: (1) their inability to be catalytically stimulated 
by DNA strand-breaks and (2) their DNA binding capacity. 
We report the identification and characterization f four loss- 
of-function mutants of the PARP DBD, located outside zinc 
fingers, that are not impaired in the DNA-binding actvity. 
2. Experimental 
2.1. Construction of the random mutagenesis plasmM library 
The internal HindlII site (position 697) of the human PARP cDNA 
was mutated by substituting the G residue for an A residue at the 
third position, conserving the codon for Lys 2'~3 in the modified cDNA 
(subsequently referred to as PARP AHindlI1). The N-terminal part 
(domains A, B and C) of human PARP encompassing the DBD was 
amplified under standard PCR conditions from the plasmid 
pTGPARPAHindlII under standard conditions using Taq polymerase 
(Stratagene). The amplified fragment (1100 bp) bearing random mu- 
tations encompasses the HindllI site (nucleotide 21 upstream of the 
ATG) and the BstEII site (nucleotide 998). Following HindlII BstElI 
restriction, the library of mutated DBD was cloned into the same sites 
of the prokaryotic expression vector pTG PARP [15], now designated 
pTG PARP*. This vector was used directly for transformation f the 
E. coli TGE 900 strain [15] from which full-length PARP-bearing 
mutations in the DBD only (PARP*) was overproduced. 
0014-5793196l$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved. 
PHS0014-5793(96)01 347-6 
314 C. Trucco et al./FEBS Letters 399 (1996) 313-316 
2.2. Colony screening for the loss-of-function PARP* mutants 
Colonies (grown at 28°C) resulting from the transformation of E. 
coli TG900 strain by pTG PARP* were replica-plated onto LB plates 
containing 50 ~tg/ml ampicillin. Nitrocellulose filter lifts were then 
made and the filters were laid, cells side up, on LB plates containing 
ampicillin. Incubation was carried out for 5 h at 37°C to induce 
protein expression. Following this induction period, poly(ADP-ribo- 
sylation) activity and immunoreactivity (using an antibody raised 
against he second zinc finger of the human PARP) were measured 
on these same filters, as described previously [16]. 
2.3. Overproduction in E. coli and analysis of the induced proteins 
L: coli TGE 900 cells transformed by either the empty vector (pTG 
161), the plasmid expressing wild-type PARP (pTG PARP), or by 
plasmids expressing the mutated PARP*, were grown at 28°C in 
2 ml of culture medium. Protein overproduction was obtained follow- 
ing a temperature shift to 37°C and further 5 h incubation. 
For DNA binding assays, the culture was centrifuged for 10 min at 
7000 × g and the proteins were dissolved in Laemmli buffer, separated 
on a 10% SDS-PAGE, and electro-transferred onto nitrocellulose. 
Following renaturation in 50 mM Tris-HC1, pH 8, 0.1 M KCI, 
2 mM MgCI2, 2 mM DTT and 0.1% Nonidet P-40 (NP40) during 
30 min, the blot was incubated for 1 h at 4°C in the DNA-binding 
buffer containing 20 ng of 32P-end-labeled double-strand DNA probe 
containing a single-strand break [17]. After three washes in binding 
buffer at 4°C, the blot was subjected to autoradiography to visualize 
the protein-DNA complexes, as described previously [10]. The relative 
amount of PARP* was then visualized on the same blots by Western 
blot technique using a polyclonal antibody, raised against he human 
recombinant PARP that had been produced in insect cells [18]. 
Synthesis of ADP-ribose polymers was measured using proteins in 
cleared lysate as follows: 2 ml of heat-induced bacterial culture was 
centrifuged and the bacteria were lysed in 1 ml of lysis buffer (0.1 M 
Tris-HCl, pH 8, 0.1 M NaCI, 1 mM EDTA, 1 mM PMSF and 1 mg/ 
ml lysozyme) for 20 min at 4°C. The lysate was then sonicated and 
complemented with Tween-20 and NP40 (both at 0.2%) and NaC1 at a 
final concentration f 0.5 M. The crude lysate was centrifuged and the 
supernatant used for a quantification by Western blot of PARP*. 
Samples of 200 ng of PARP*, in crude extracts, were used for enzy- 
matic activity measurement according to [19]. 
3. Results and discussion 
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Fig. 1. A: Modular organisation of the human poly(ADP-ribose) 
polymerase. The DBD encompasses modules A, B and C; module 
D is referred to the automodification domain, and the catalytic do- 
main is located in modules E and F. The active site is located in re- 
gion 85%908 [14] B: Protocol used to generate by PCR a random 
library of PARP* mutated exclusively in the amino-terminal region 
(residues 1-333). 
Random mutagenesis a powerful method for the identi- 
fication of critical residues involved in a given enzymatic func- 
tion. We have previously reported the isolation and character- 
ization of a gain-of-function PARP mutant, L713F, generated 
by hydroxylamine random mutagenesis of the catalytic do- 
main [20]. Whereas hydroxylamine preferentially modifies 
GC nucleotides, the errors made by Taq polymerase are 
more random over the entire genome. In this paper, we 
have generated mutants of the DBD of PARP, using PCR. 
To screen for a subsequent loss of function, we have exploited 
the activity blot procedure described previously [16]. 
The methodology used for random mutagenesis is illu- 
strated in Fig. 1B. A Hindl I I -BstE I I  fragment of the human 
PARP cDNA encoding the DBD (module A), the nuclear 
localization signal [12] (module B) and module C (unknown 
function), was amplified by PCR, restricted and cloned back 
into the same sites of the prokaryotic expression vector pTG 
PARP, giving rise to a library of DBD-mutated PARP* (res- 
idues 1-333). The rate of PCR random mutagenesis was 
about 2%. Screening for PARP activity on replica filters re- 
vealed colonies with no enzymatic activity; however, the im- 
munostaining reaction detected PARP protein (data not 
shown) indicating that these colonies could be expressing 
loss-of-function mutants. 
Polymerizing activity of PARP* mutants in cleared lysate 
was quantified in vitro according to the standard procedure 
[19]. As displayed in Table 1, these mutants retain less than 
1.5% of the enzymatic activity stimulated by DNA strand- 
breaks, compared to the wild-type PARP expressed and solu- 
bilized under the same conditions. 
Table 1 
Identification and location of the mutations and residual enzymatic activity of the corresponding PARP* mutants 
Mutated amino acid Mutated nucleotide Mutated module* Enzymatic activity** 
(%) 
L77P T230C A < 0.5% 
K97R A290G A < 0.5% 
K249E A745G C < 0.5% 
G313E G938A C 1.5% 
* See Fig. 1A. 
**Percentage of the enzymatic activity of the mutated PARP* compared to the wild-type (see Section 2). 
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tig. 2. DNA-binding capacity of the mutated PARP* overproduced 
iT E. coli compared to the wild-type PARP; pTG161 indicates 
t'.ansformation f bacteria with the empty vector, C21G and C21G; 
( 125G are site directed point mutants [10]. (A) Southwestern blot- 
ting using a 32p-end-labelled nicked DNA probe; (B) Western blot 
analysis using a polyclonal antibody raised against the human 
PARP. The same nitrocellulose sheet was used for both experi- 
rlents. 
The corresponding cDNAs were sequenced on both 
strands; in each case a single nucleotide change was found. 
"l'able 1 summarizes the location and the nature of the muta- 
tions. Two mutations were located in domain A between the 
~wo zinc fingers. L77P is a non-conservative mutation that 
raay induce strong changes in the secondary structure of the 
protein; however, the second mutation, K97R, is conserva- 
tive. This mutation strongly suggests that although the posi- 
live charge of the amino acid is conserved, modification of the 
~ature of the basic side chain cannot be tolerated. One hy- 
t~othesis could be that the spatial conformation of residue K97 
'~ modulated by the interaction between the zinc fingers and 
~he DNA breaks. This residue could be a relay informing the 
~atalytic domain that the DBD is bound to an interruption of
~he sugar-phosphate backbone in the DNA. The two others 
nutations (K249E and G313E) fall in domain C whose func- 
tion is unknown, underlying the importance of this region for 
he stimulation of the catalytic activity by DNA strand- 
~reaks. One cannot rule out the contribution of these muta- 
ions to a possible inhibition of the formation of a catalytic 
timer which constitutes an essential step in the automodifica- 
ion reaction [21]. 
It is interesting to note that both amino acids mutated in 
domain A are strictly and evolutionary conserved in all PARP 
-,equences as well as in the N-terminal part of the DNA ligase 
I I  which encompasses a putative zinc finger-sharing homol- 
)gy with those of PARP [22]. This finding reinforces the hy- 
i~othesis that an ancestral motif encompassing exactly the two 
irst exons has been duplicated and integrated into PARP and 
ONA ligase III sequences. 
Given that PARP activity is strongly dependent upon the 
:;)resence of DNA strand-breaks [23], PARP* mutants were 
~:ested for their DNA-binding capacity using a Southwestern 
i)lot assay as described in [10]. Additionaly, site-directed point 
mutants were tested in parallel: the mutation C21G affecting 
the structure of the first zinc finger retains a full capacity to 
bind to nicked DNA whereas the double mutant (C21G; 
315 
C125G) mutated in the zinc ligands of both fingers displays 
a strongly reduced DNA-binding capacity [10]. As shown in 
Fig. 2A, all PARP* mutants obtained by PCR mutagenesis 
surprisingly retain a full capacity to bind to nicked DNA as 
compared to the wild-type protein. The same blot was immu- 
nostained with an antibody raised againt the full-length u- 
man PARP (Fig. 2B) to monitor the amount of protein 
loaded. 
In conclusion, we have shown that a simple relationship 
between binding to a DNA interruption and PARP activation 
does not exist. Our data strongly suggest that PARP* mutants 
may bind to a nick in an inactive form even though the con- 
formation of the DBD is slightly altered. This may be of 
biological importance since association of the DBD with in- 
teracting protein(s) could induce structural changes that mim- 
ick the structural alterations observed in the mutants we 
have generated, serving to negatively modulate PARP activity 
at the site of a DNA break. Using the 2-hybrid system, we 
have fished out genes encoding proteins that at the same time 
interacts with the DBD and impair PARP function (unpub- 
lished data). Further work is in progress to test this hypoth- 
esis. 
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